Propiedad y actividad de insiders de Spyre Therapeutics, Inc. (SYRE): operaciones de insiders, transacciones del Senado y la Cámara de EE. UU. y acciones en circulación. Sigue cómo operan la acción los directivos y los políticos.
Precio
| Precio | $91.17 |
| Capitalización | $7.9B |
| Bolsa | NASDAQ |
| País | US |
Operaciones Recientes de Insiders
| Fecha | Insider | Tipo | Acciones | Valor |
|---|---|---|---|---|
| 2026-09-01 | King-Jones Heidy | M-Exempt | 27,999 | $406K |
| 2026-09-02 | King-Jones Heidy | M-Exempt | 400 | $6K |
| 2026-09-01 | King-Jones Heidy | M-Exempt | 27,999 | $406K |
| 2026-09-01 | King-Jones Heidy | S-Sale | 4,845 | $419K |
| 2026-09-01 | King-Jones Heidy | S-Sale | 16,548 | $1.4M |
| 2026-09-01 | King-Jones Heidy | S-Sale | 6,206 | $547K |
| 2026-09-02 | King-Jones Heidy | M-Exempt | 400 | $6K |
| 2026-09-01 | King-Jones Heidy | S-Sale | 400 | $36K |
| 2026-09-02 | King-Jones Heidy | S-Sale | 400 | $36K |
| 2026-09-01 | Burrows Scott L | M-Exempt | 7,500 | $109K |
Balance (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $47.7M | $12.8M | $22.5M | $19.3M | $90.1M | $15.1M | $34.9M | $188.9M | $89.4M | $85.7M |
| Inversiones a Corto | $15.8M | $37.5M | $52.1M | $52.7M | $56.2M | $78.0M | $20.8M | $150.4M | $513.7M | $670.8M |
| Cuentas por Cobrar | $1.2M | $3.1M | 0 | 0 | 0 | $815000 | $375000 | 0 | 0 | 0 |
| Inventario | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $66.4M | $55.0M | $76.7M | $74.5M | $149.8M | $98.9M | $62.3M | $341.5M | $608.5M | $777.8M |
| Inmovilizado Material | $599000 | $854000 | $1.0M | $7.1M | $9.9M | $8.4M | $6.7M | 0 | 0 | 0 |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Totales | $67.1M | $56.1M | $77.7M | $83.2M | $161.6M | $109.9M | $71.1M | $341.9M | $608.5M | $777.8M |
| Cuentas por Pagar | $168000 | $389000 | $663000 | $3.2M | $2.3M | $3.3M | $677000 | $896000 | $666000 | $8.9M |
| Deuda a Corto | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Corrientes | $4.0M | $5.6M | $10.2M | $18.4M | $16.4M | $20.1M | $14.7M | $32.0M | $54.1M | $58.7M |
| Deuda a Largo | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Totales | $4.1M | $5.7M | $10.3M | $23.1M | $21.8M | $26.0M | $20.8M | $157.8M | $90.7M | $62.5M |
| Reservas | -$45.3M | -$72.5M | -$116.9M | -$195.1M | -$276.0M | -$341.8M | -$425.6M | -$764.4M | -$972.4M | -$1.13B |
| Patrimonio Neto | $63.0M | $50.3M | $67.4M | $60.1M | $139.8M | $83.9M | $50.3M | $184.0M | $517.8M | $715.2M |
| Deuda Total | 0 | 0 | 0 | $5.1M | $5.4M | $5.1M | $4.6M | 0 | 0 | 0 |
| Deuda Neta | -$63.5M | -$50.3M | -$74.5M | -$66.9M | -$140.8M | -$88.1M | -$51.1M | -$339.3M | -$603.1M | -$756.5M |
| Capital Circulante | $62.5M | $49.4M | $66.4M | $56.1M | $133.3M | $78.7M | $47.6M | $309.6M | $554.4M | $719.1M |
Salud financiera
| Deuda / Patrimonio | 0.00 |
| Ratio corriente | 18.53 |
Rentabilidad
| Margen bruto | 0.00% |
| Margen operativo | -222.49% |
| Margen neto | -197.71% |
Empresas relacionadas: ABCL · ARDX · CLDX · IMNM · MAZE · NTLA · PHVS
Explorar sector: Healthcare · Biotechnology
Más secciones de SYRE: Resumen · Financieros · Valoración · Estadísticas · Estimaciones · Técnico · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones